Director/PDMR Shareholding
9 March 2022 15:30 GMT Transaction by Person Discharging Managerial Responsibilities AstraZeneca PLC (the Company) announced that, on 8 March 2022, an award of the Company's ordinary shares of $0.25 each (Ordinary Shares) vested to Pascal Soriot, Executive Director and Chief Executive Officer, under the terms of the AstraZeneca Deferred Bonus Plan (AZDBP). The AZDBP award was granted on 8 March 2019, following the deferral of a portion of Mr Soriot's annual bonus in respect of 2018 performance into Ordinary Shares, and vested on completion of the three-year